Ken Griffin Akoya Biosciences, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 18,000 shares of AKYA stock, worth $41,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,000
Previous 24,100
25.31%
Holding current value
$41,580
Previous $65,000
36.92%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AKYA
# of Institutions
59Shares Held
12.2MCall Options Held
46.6KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$10.9 Million9.79% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$3.25 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX801KShares$1.85 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA565KShares$1.31 Million0.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $87.5M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...